Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “BIOMARIN PHARMACEUTICAL INC.”

112 pharma patents match "BIOMARIN PHARMACEUTICAL INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 112
Index total 30,257
Page 5 / 5

Quick answer

This filtered view shows 112 pharmaceutical patents matching "BIOMARIN PHARMACEUTICAL INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

112 results for “BIOMARIN PHARMACEUTICAL INC.” · 30,257 patents in full index Clear search

  1. US 7722865

    Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted May 25, 2010 · Expires May 20, 2030

    granted
  2. US 7612073

    Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring

    BIOMARIN PHARMACEUTICAL INC. · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  3. US 7601717

    Pterin analogs

    BIOMARIN PHARMACEUTICAL INC. · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted
  4. US 7566462

    Stable tablet formulation

    BIOMARIN PHARMACEUTICAL INC. · Granted Jul 28, 2009 · Expires Jul 23, 2029

    granted
  5. US 7566714

    Methods and compositions for the treatment of metabolic disorders

    BIOMARIN PHARMACEUTICAL INC. · Granted Jul 28, 2009 · Expires Jul 23, 2029

    granted
  6. US 7560263

    Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Jul 14, 2009 · Expires Jul 9, 2029

    granted
  7. US 7553653

    Variants and chemically-modified variants of phenylalanine ammonia-lyase

    BIOMARIN PHARMACEUTICAL INC. · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted
  8. US 7537923

    Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted May 26, 2009 · Expires May 21, 2029

    granted
  9. US 7534595

    Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted May 19, 2009 · Expires May 14, 2029

    granted
  10. US 7531341

    Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted May 12, 2009 · Expires May 7, 2029

    granted
  11. US 7442372

    Delivery of therapeutic compounds to the brain and other tissues

    BIOMARIN PHARMACEUTICAL INC. · Granted Oct 28, 2008 · Expires Oct 23, 2028

    granted
  12. US 7354576

    Methods of treating diseases caused by deficiencies of recombinant α-L-iduronidase

    BIOMARIN PHARMACEUTICAL INC. · Granted Apr 8, 2008 · Expires Apr 3, 2028

    granted
  13. US 7264799

    Use of heparinases to decrease inflammatory response

    BIOMARIN PHARMACEUTICAL INC. · Granted Sep 4, 2007 · Expires Aug 30, 2027

    granted
  14. US 6972124

    Precursor of N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme

    BIOMARIN PHARMACEUTICAL INC. · Granted Dec 6, 2005 · Expires Dec 1, 2025

    expired
  15. US 6866844

    Precursor N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme

    BIOMARIN PHARMACEUTICAL INC. · Granted Mar 15, 2005 · Expires Mar 10, 2025

    expired
  16. US 6569661

    Recombinant &agr;-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted May 27, 2003 · Expires May 22, 2023

    expired